Seeking Alpha HealthcareOriginal article
Sophia Genetics outlines $94M-$96M 2026 revenue outlook as it targets adjusted EBITDA breakeven by year-end
EarningsPositive
AI Analysis
Summary
Sophia Genetics provided 2026 revenue guidance of $94M-$96M and announced a target to achieve adjusted EBITDA breakeven by year-end 2026.
Financial Highlights
Revenue
$94M-$96M
Guidance
2026 revenue outlook of $94M-$96M; targeting adjusted EBITDA breakeven by year-end 2026
Importance:4/10
Sentiment:
0.40
guidancerevenueprofitabilityfinancial outlook
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on August 4, 2026 9:11 PM